NO152751C - Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat. - Google Patents

Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat.

Info

Publication number
NO152751C
NO152751C NO742986A NO742986A NO152751C NO 152751 C NO152751 C NO 152751C NO 742986 A NO742986 A NO 742986A NO 742986 A NO742986 A NO 742986A NO 152751 C NO152751 C NO 152751C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic effective
cephalosporin derivative
analogy procedure
effective cephalosporin
Prior art date
Application number
NO742986A
Other languages
English (en)
Norwegian (no)
Other versions
NO742986L (fr
NO152751B (no
Inventor
Martin Christopher Cook
Gordon Ian Gregory
Janice Bradshaw
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10410683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO152751(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NO742986L publication Critical patent/NO742986L/no
Publication of NO152751B publication Critical patent/NO152751B/no
Publication of NO152751C publication Critical patent/NO152751C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO742986A 1973-08-21 1974-08-20 Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat. NO152751C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3964573A GB1453049A (en) 1973-08-21 1973-08-21 Cephalosporing antibiotics

Publications (3)

Publication Number Publication Date
NO742986L NO742986L (fr) 1975-03-17
NO152751B NO152751B (no) 1985-08-05
NO152751C true NO152751C (no) 1985-11-13

Family

ID=10410683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742986A NO152751C (no) 1973-08-21 1974-08-20 Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat.

Country Status (32)

Country Link
JP (2) JPS562077B2 (fr)
AR (2) AR212076A1 (fr)
AT (1) AT340042B (fr)
AU (1) AU473550B2 (fr)
BE (1) BE819004R (fr)
BG (2) BG23903A3 (fr)
CA (1) CA1057283A (fr)
CH (2) CH613975A5 (fr)
CS (2) CS204988B2 (fr)
CY (1) CY945A (fr)
DD (1) DD114417A5 (fr)
DE (2) DE2439880C3 (fr)
DK (1) DK147683C (fr)
ES (2) ES429388A1 (fr)
FI (1) FI65623C (fr)
FR (1) FR2241318B2 (fr)
GB (1) GB1453049A (fr)
GT (1) GT198302370A (fr)
HK (1) HK17378A (fr)
HU (1) HU170000B (fr)
IE (1) IE39764B1 (fr)
IL (1) IL45505A (fr)
KE (1) KE2816A (fr)
LU (2) LU88269I2 (fr)
MY (1) MY7800188A (fr)
NL (1) NL154741B (fr)
NO (1) NO152751C (fr)
PL (2) PL115805B1 (fr)
RO (2) RO64129A (fr)
SU (1) SU633483A3 (fr)
YU (2) YU36737B (fr)
ZA (1) ZA745331B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (fr) * 1976-02-16 1981-01-13 Michael Gregson Traduction non-disponible
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
FI771866A (fr) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
FR2414509A1 (fr) * 1978-01-17 1979-08-10 Glaxo Group Ltd Procede de cristallisation de cefuroxime sodique
DE2804040C3 (de) * 1978-01-31 1981-03-19 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Cephemverbindungen
US4341777A (en) * 1979-09-10 1982-07-27 Glaxo Group Limited Cephalosporin antibiotic
IT1190734B (it) * 1982-03-11 1988-02-24 Opos Biochimica Srl Procedimento per la preparazione di cefuroxima e intermedi impiegati in tale procedimento
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
WO2000053609A1 (fr) * 1999-03-09 2000-09-14 Ranbaxy Laboratories Limited Procede de preparation de cefuroxime
US20040191803A1 (en) * 2002-11-22 2004-09-30 Michela Gallagher Target for therapy of cognitive impairment
WO2004050663A2 (fr) * 2002-12-05 2004-06-17 Orchid Chemicals & Pharmaceuticals Ltd Procede ameliore de preparation de cefuroxime sodique
JP2008275173A (ja) * 2008-08-04 2008-11-13 Toshiba Corp 分岐配管
EP2741750A1 (fr) 2011-08-12 2014-06-18 Dhanuka Laboratories Ltd. Composition pharmaceutique comprenant du céfuroxime
WO2013038323A1 (fr) 2011-09-13 2013-03-21 Unimark Remedies Ltd. Compositions pharmaceutiques de céfuroxime axétil à goût masqué
KR101497420B1 (ko) 2013-07-05 2015-03-03 삼성중공업 주식회사 증발가스 저감용 액화천연가스 수송장치
CN105884799A (zh) * 2015-09-23 2016-08-24 石药集团中诺药业（石家庄）有限公司 一种新的头孢呋辛钠化合物

Also Published As

Publication number Publication date
DK443274A (fr) 1975-04-28
LU70765A1 (fr) 1975-12-09
CH615931A5 (en) 1980-02-29
ES437269A1 (es) 1977-01-01
FI65623C (fi) 1984-06-11
JPS5649388A (en) 1981-05-02
CS204988B2 (en) 1981-04-30
IE39764B1 (en) 1978-12-20
IL45505A (en) 1979-01-31
ZA745331B (en) 1975-10-29
PL98962B1 (pl) 1978-06-30
CH613975A5 (en) 1979-10-31
DE2462376A1 (de) 1976-11-25
BE819004R (fr) 1975-02-20
HK17378A (en) 1978-04-07
YU41231B (en) 1986-12-31
DD114417A5 (fr) 1975-08-05
HU170000B (fr) 1977-03-28
JPS562077B2 (fr) 1981-01-17
GB1453049A (en) 1976-10-20
YU30781A (en) 1983-02-28
CA1057283A (fr) 1979-06-26
IL45505A0 (en) 1974-11-29
ES429388A1 (es) 1976-08-16
FI65623B (fi) 1984-02-29
AT340042B (de) 1977-11-25
DE2439880B2 (de) 1979-02-22
NL154741B (nl) 1977-10-17
BG23903A3 (en) 1977-11-10
AR212076A1 (es) 1978-05-15
JPS5052083A (fr) 1975-05-09
NO742986L (fr) 1975-03-17
BG25801A3 (en) 1978-12-12
MY7800188A (en) 1978-12-31
LU88269I2 (fr) 1994-02-03
NL7411095A (nl) 1975-02-25
YU228374A (en) 1982-06-18
NO152751B (no) 1985-08-05
DK147683C (da) 1985-05-13
RO69607A (fr) 1980-08-15
FI245674A (fr) 1975-02-22
CY945A (en) 1978-06-23
FR2241318A2 (fr) 1975-03-21
DE2439880A1 (de) 1975-04-03
AU473550B2 (en) 1976-06-24
IE39764L (en) 1975-02-21
KE2816A (en) 1978-02-24
RO64129A (fr) 1979-03-15
GT198302370A (es) 1984-11-20
FR2241318B2 (fr) 1979-08-10
AU7253174A (en) 1976-02-26
ATA676374A (de) 1977-03-15
PL115805B1 (en) 1981-05-30
DE2439880C3 (de) 1979-10-18
AR212156A1 (es) 1978-05-31
CS204989B2 (en) 1981-04-30
DK147683B (da) 1984-11-12
YU36737B (en) 1984-08-31
SU633483A3 (ru) 1978-11-15

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO152751C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat.
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO142441C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater
SE409707B (sv) Forfarande for framstellning av sulfoxider, vilka er antagonister mot vissa verkningar av histamin
NO146432C (no) Analogifremgangsmaate ved fremstilling av et dihydrokarbostyrilderivat
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
SE415834B (sv) Analogiforfarande for framstellning av pyrazolderivat
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO142221C (no) Analogifremgangsmaate ved fremstilling av antibakterielt virksomme piperazinderivater
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO141341C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
SE418293B (sv) Forfarande for framstellning av cefalosporinforeningar med en karbamoyloximetylsubstituent i 3-stellning
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
NO148376C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser
NO153221C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner.
NO144018C (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser